Correlation Between Adverum Biotechnologies and Pieris Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adverum Biotechnologies and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adverum Biotechnologies and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adverum Biotechnologies and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Adverum Biotechnologies and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adverum Biotechnologies with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adverum Biotechnologies and Pieris Pharmaceuticals.

Diversification Opportunities for Adverum Biotechnologies and Pieris Pharmaceuticals

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Adverum and Pieris is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Adverum Biotechnologies and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Adverum Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adverum Biotechnologies are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Adverum Biotechnologies i.e., Adverum Biotechnologies and Pieris Pharmaceuticals go up and down completely randomly.

Pair Corralation between Adverum Biotechnologies and Pieris Pharmaceuticals

Given the investment horizon of 90 days Adverum Biotechnologies is expected to under-perform the Pieris Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Adverum Biotechnologies is 2.24 times less risky than Pieris Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Pieris Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  1,020  in Pieris Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  605.00  from holding Pieris Pharmaceuticals or generate 59.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Adverum Biotechnologies  vs.  Pieris Pharmaceuticals

 Performance 
       Timeline  
Adverum Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adverum Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Adverum Biotechnologies is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Pieris Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pieris Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Pieris Pharmaceuticals is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Adverum Biotechnologies and Pieris Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adverum Biotechnologies and Pieris Pharmaceuticals

The main advantage of trading using opposite Adverum Biotechnologies and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adverum Biotechnologies position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.
The idea behind Adverum Biotechnologies and Pieris Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Content Syndication
Quickly integrate customizable finance content to your own investment portal